FDA Orange Book

Is there a generic for Akten?

Akten contains lidocaine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Akten (lidocaine). The Orange Book shows its last listed patent expires July 24, 2026.

Run it in Rivvi

Map Akten and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Akten products in the Orange Book

Akten products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
gel, ophthalmic3.5%Marketed (Rx)None0None

NDA 022221, held by THEA PHARMA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Akten patents

Patents listed for Akten
PatentExpiresCoversUse codeNDA
8759401July 24, 2026Drug productU-1523022221

Akten NDC codes

Questions

Is there a generic for Akten?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Akten (lidocaine). The Orange Book shows its last listed patent expires July 24, 2026.

What is the generic name for Akten?

The active ingredient in Akten is lidocaine, per the FDA Orange Book.

When does the Akten patent expire?

The last patent listed for Akten in the Orange Book expires July 24, 2026. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Akten and Lidocaine

Try it on your own data today.

Free to start. Most teams are using it the same day.